Pharmacological properties of revefenacin (TD‐4208), a novel, nebulized long‐acting, and lung selective muscarinic antagonist, at human recombinant muscarinic receptors and in rat, guinea pig, and human isolated airway tissues.

Autor: Hegde, Sharath S.1 shegde@theravance.com, Pulido‐Rios, M. Teresa1, Luttmann, Mark A.2, Foley, James J.2, Hunsberger, Gerald E.2, Steinfeld, Tod1, Lee, TaeWeon1, Ji, Yuhua1, Mammen, Mathai M.1, Jasper, Jeffrey R.1
Zdroj: Pharmacology Research & Perspectives. Jun2018, Vol. 6 Issue 3, p1-1. 11p.
Databáze: Academic Search Ultimate